StockData
MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics (MLTX) stock

MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$11.25−0.48 (-4.09%)

Close on Nov 17, 2026Market cap $957.45MP/E –Yield –

MoonLake Immunotherapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

MoonLake Immunotherapeutics's price to book ratio was 2.2× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 1.3× to 54.7×, with a median of 5.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.2×−0.7
2025Dec 31, 20252.9×−4.0
2024Dec 31, 20246.9×+0.6
2023Dec 29, 20236.3×+1.7
2022Dec 30, 20224.5×–

More MoonLake Immunotherapeutics figures

See a number that looks wrong?